Latest from ISC 2017

Intensive Antiplatelet Therapy and Risk of Recurrent Stroke

Intensive Antiplatelet Therapy and Risk of Recurrent Stroke

Efficacy of triple antiplatelet therapy compared with current guideline-based therapy for the prevention of recurrent stroke was evaluated in the TARDIS trial.

Vagus Nerve Stimulation May Improve Stroke Recovery

Vagus Nerve Stimulation May Improve Stroke Recovery

More patients receiving VNS experienced enhanced arm movement over a 90-day period.

Oral Anticoagulation After ICH: Risks and Outcomes

Oral Anticoagulation After ICH: Risks and Outcomes

Restarting anticoagulation after both nonlobar and lobar ICH was associated with decreased mortality.

Is There Gender Bias in Stroke Care?

Is There Gender Bias in Stroke Care?

Men were more likely than women to be treated with IV tPA within 30 minutes of arrival at a hospital.

Medical Complications After ICH: Changes in the Last Decade

Medical Complications After ICH: Changes in the Last Decade

As more patients survive ICH, emphasis is slowly shifting from survival to improving ICH-related morbidity and optimization of functional recovery.

Contact Aspiration vs Stent Retriever in Acute Ischemic Stroke

Contact Aspiration vs Stent Retriever in Acute Ischemic Stroke

The results provide good evidence for the use of contact aspiration in ischemic stroke.

Cilostazol Helps Prevent Secondary Stroke But Not Without Risk

Cilostazol Helps Prevent Secondary Stroke But Not Without Risk

Optimal antiplatelet treatment has yet to be determined for stroke survivors with prior intracerebral hemorrhage.

Comorbid Headache, Stroke Common in Pediatric Patients

Comorbid Headache, Stroke Common in Pediatric Patients

The co-presentation of headache at stroke onset in children may provide clues to underlying pathophysiologic mechanisms.

Acute Stroke Risk Elevated in Patients With Psychiatric Illness

Acute Stroke Risk Elevated in Patients With Psychiatric Illness

Psychological distress may cause changes within cells that trigger inflammation and oxidative stress, both of which are believed to increase stroke risk.

Time to Alteplase Treatment Affected by Hospital Delays, Medical Conditions

Time to Alteplase Treatment Affected by Hospital Delays, Medical Conditions

Delays related to the determination of treatment eligibility increased door-to-needle times by more than 30 minutes compared with patients with no delays.